The demanding nature of developing and manufacturing GMP peptides can often be a significant barrier to researchers. Fortunately, Contract Development and Manufacturing Organizations (CDMOs) have emerged as valuable partners in this industry. With specialized expertise and advanced facilities, CDMOs can expedite the development process, enabling co